In terms of safety, the incidence of CRS in different co-stimulatory domains was similar, but the incidence of neurotoxicity in the CD28 co-stimulatory domain was significantly higher than that in the 4-1BB co-stimulatory domain. The gene discussed is CD28; the disease is congenital rubella syndrome.